Cathay Biotech Inc.
688065.SS · SHH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | CN¥37,414,087 | CN¥33,862,480 | CN¥29,962,303 | CN¥22,585,384 |
| - Cash | CN¥8,106,448 | CN¥8,720,311 | CN¥10,797,271 | CN¥5,346,794 |
| + Debt | CN¥279,227 | CN¥543,070 | CN¥1,635,744 | CN¥1,860,175 |
| Enterprise Value | CN¥29,586,866 | CN¥25,685,239 | CN¥20,800,776 | CN¥19,098,765 |
| Revenue | CN¥874,273 | CN¥894,998 | CN¥775,770 | CN¥742,828 |
| % Growth | -2.3% | 15.4% | 4.4% | – |
| Gross Profit | CN¥319,015 | CN¥246,874 | CN¥260,919 | CN¥123,214 |
| % Margin | 36.5% | 27.6% | 33.6% | 16.6% |
| EBITDA | CN¥164,269 | CN¥186,675 | CN¥222,126 | CN¥72,540 |
| % Margin | 18.8% | 20.9% | 28.6% | 9.8% |
| Net Income | CN¥142,007 | CN¥171,717 | CN¥136,950 | CN¥143,784 |
| % Margin | 16.2% | 19.2% | 17.7% | 19.4% |
| EPS Diluted | 0.2 | 0.24 | 0.23 | 0.25 |
| % Growth | -16.7% | 4.3% | -8% | – |
| Operating Cash Flow | -CN¥66,221 | CN¥251,824 | CN¥87,489 | CN¥144,913 |
| Capital Expenditures | -CN¥187,865 | -CN¥78,508 | -CN¥279,727 | -CN¥199,364 |
| Free Cash Flow | -CN¥254,085 | CN¥173,316 | -CN¥192,238 | -CN¥54,450 |